Alcatraz Therapeutics being awarded “New Company with more transformative potential” at Bio-Neurosciences 2025
Alcatraz Therapeutics being awarded “New Company with more transformative potential” at Bio-Neurosciences 2025 Amsterdam (The Netherlands) – We are excited to share that Stefan Lohmer, ad interim CEO of Alcatraz Therapeutics, recently presented the company at BioNeuroscience 2025 in Amsterdam. Alcatraz Therapeutics has been honored with the “New Company with more transformative potential” award! Currently … Read more